Clecell Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 2

Clecell General Information

Description

Developer of a 3D bioprinting company focused on the research and development of artificial tissue. The company is engaged in developing artificial human skin models as well as producing respiratory epithelium artificial tissue with the help of its proprietary 3D bioprinter and other bioprinting technology, enabling clients to prevent infection and tissue injury through the use of the mucociliary elevator.

Contact Information

Website
www.clecell.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Healthcare Innovation Park H6107
  • 172 Dolma-ro
  • Seongnam, Gyeonggi
  • South Korea
+82
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Biotechnology
Machinery (B2B)
Vertical(s)
3D Printing
Corporate Office
  • Healthcare Innovation Park H6107
  • 172 Dolma-ro
  • Seongnam, Gyeonggi
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clecell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round Completed Generating Revenue
To view Clecell’s complete valuation and funding history, request access »

Clecell Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Clecell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230173750-A1 Leakage prevention system for downward spraying-type nebulizer for stacking a biomaterial of bio-3d printer Pending 05-Aug-2020
JP-2023536513-A Leak-proof system of bottom-firing nebulizer for biomaterial deposition in bio-3d printers Pending 05-Aug-2020
EP-4194181-A1 Leakage prevention system for downward spraying-type nebulizer for stacking biomaterial of bio-3d printer Pending 05-Aug-2020
EP-4194181-A4 Leakage prevention system for downward spraying-type nebulizer for stacking biomaterial of bio-3d printer Pending 05-Aug-2020
US-20220073849-A1 Suspension maintenance method, suspension maintenance apparatus, and bio 3d printer including same Pending 14-Mar-2019 B29C64/209
To view Clecell’s complete patent history, request access »

Clecell Executive Team (3)

Name Title Board Seat
Wonseok Woo President & Chief Strategy Officer
Bongsun Kim Co-Chief Marketing Officer
SuYun Chae Co-Chief Marketing Officer
To view Clecell’s complete executive team members history, request access »

Clecell Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Honest Ventures Venture Capital Minority
UTC Investment Asset Manager Minority
To view Clecell’s complete investors history, request access »

Ready to get started?

Request a free trial

Clecell FAQs

  • When was Clecell founded?

    Clecell was founded in 2017.

  • Where is Clecell headquartered?

    Clecell is headquartered in Seongnam, South Korea.

  • What industry is Clecell in?

    Clecell’s primary industry is Other Devices and Supplies.

  • Is Clecell a private or public company?

    Clecell is a Private company.

  • What is Clecell’s current revenue?

    The current revenue for Clecell is .

  • Who are Clecell’s investors?

    Honest Ventures and UTC Investment have invested in Clecell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »